Disposables Advisor

Jun 01, 2008
BioPharm International
The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.
Apr 01, 2008
BioPharm International
Disposable technologies that mimic the conventional stainless-steel bioreactor will be most readily adopted
Feb 01, 2008
BioPharm International
The use of disposables has changed significantly in the biopharmaceutical industry.
lorem ipsum